---
name: Systemic Lupus Erythematosus
description: An autoimmune multi-organ disease typically associated with vasculopathy and autoantibody production. Most patients have antinuclear antibodies (ANA). The presence of anti-dsDNA or anti-Smith antibodies are highly-specific
category: Complex
parents:
  - Autoimmune Disease
has_subtypes:
  - name: Discoid Lupus Erythematosus
    description: Primarily affects the skin.
    evidence:
      - reference: PMID:30988213
        supports: SUPPORT
        snippet: The representatives of the chronic and acute types are discoid lupus erythematosus (DLE) and butterfly rash, respectively. Based on the systemic manifestations, we can classify LE into cutaneous-limited LE and systemic LE (SLE). Chronic LE eruptions tend to be seen in cutaneous-limited LE, and acute LE eruptions mainly appear in SLE.
        explanation: Discoid Lupus Erythematosus (DLE) is a chronic cutaneous form of lupus erythematosus primarily affecting the skin.
      - reference: PMID:7763220
        supports: SUPPORT
        snippet: Discoid lupus erythematosus is a manifestation of chronic cutaneous lupus erythematosus with a small risk of systemic involvement.
        explanation: This reference confirms that Discoid Lupus Erythematosus primarily affects the skin.
      - reference: PMID:28941498
        supports: SUPPORT
        snippet: Cutaneous lupus erythematosus, specifically discoid lupus erythematosus, disproportionately affects those with skin of color and may result in greater dyspigmentation and scarring in darker skin types.
        explanation: This reference confirms the primary cutaneous impact of Discoid Lupus Erythematosus.
  - name: Neonatal Lupus
    description: Affects infants, caused by transplacental transfer of maternal autoantibodies.
    evidence:
      - reference: PMID:9287379
        supports: SUPPORT
        snippet: neonatal lupus erythematosus is likely the result of fetal or neonatal tissue damage caused by maternally transmitted IgG autoantibodies.
        explanation: This describes neonatal lupus erythematosus as a subtype of lupus erythematosus affecting newborns due to the transplacental transfer of maternal autoantibodies.
      - reference: PMID:24763535
        supports: SUPPORT
        snippet: Another complication may be neonatal lupus (NL), mediated by the presence of maternal antibodies (anti-Ro/SSA and anti-La/SSB).
        explanation: The reference notes that neonatal lupus is mediated by maternal autoantibodies, supporting the statement.
      - reference: PMID:15744116
        supports: SUPPORT
        snippet: Neonatal lupus syndrome is a passively acquired autoimmune syndrome in which pathogenic autoantibodies (anti-SSA/Ro, anti-SSB/La... antibodies) are transmitted from a mother to her fetus through the placenta.
        explanation: This confirms that neonatal lupus is a result of the transplacental transfer of maternal antibodies.
      - reference: PMID:3521977
        supports: SUPPORT
        snippet: 'Lupus erythematosus in childhood comprises the following distinctive lupus subsets: neonatal lupus erythematosus...'
        explanation: This supports the classification of neonatal lupus erythematosus as a subtype affecting children due to maternal factors.
      - reference: PMID:22832822
        supports: PARTIAL
        snippet: Cardiac manifestations of neonatal lupus include anti-SSA/Ro-SSB/La-mediated conduction system disease and endocardial/myocardial damage resulting in cardiomyopathy.
        explanation: This reference implies that neonatal lupus caused by maternal autoantibodies affects the heart but doesn't explicitly say it's a systemic lupus erythematosus subtype.
  - name: Drug-Induced Lupus
    description: Caused by certain medications and usually reversible.
    evidence:
      - reference: PMID:1356074
        supports: SUPPORT
        snippet: The epidemiologic characteristics of medication-induced SLE (MI-SLE) are different from those of idiopathic SLE... Hydralazine and procainamide are the most commonly recognized medications for inducing SLE.
        explanation: This indicates that there is a distinct subtype of SLE induced by medications.
      - reference: PMID:23164669
        supports: SUPPORT
        snippet: Drug-induced lupus erythematosus (DILE) refers to a condition whose clinical, histological, and immunological features are similar to those seen in idiopathic lupus erythematosus but that occurs when certain drugs are taken and resolves after their withdrawal.
        explanation: This explicitly states that drug-induced lupus erythematosus (DILE) is caused by certain medications and is usually reversible after discontinuation of the drug.
      - reference: PMID:1751313
        supports: SUPPORT
        snippet: All physicians should be alerted to the many drugs and other agents that are associated with drug-related lupus, as there is an increasing number of such drugs... Continued study of this human experimental model of lupus will help to clarify the etiology and mechanisms of systemic lupus erythematosus itself.
        explanation: This literature mentions that certain drugs are associated with drug-related lupus, providing further support to the statement.
      - reference: PMID:25037258
        supports: SUPPORT
        snippet: This article discusses the clinical presentation, time frames, reported culprit medications, pathophysiology and management of drug-induced lupus...
        explanation: This article covers drug-induced lupus, affirming the existence of this subtype linked to medications.
pathophysiology:
  - name: Formation of Immune Complexes
    cell_types:
      - B cell
      - plasma cell
      - macrophage
    evidence:
      - reference: PMID:27709413
        supports: PARTIAL
        snippet: Here, we review what is known on the altered metabolic patterns of CD4(+) T cells, B cells, and myeloid cells in lupus patients and lupus-prone mice and how they contribute to lupus pathogenesis.
        explanation: The reference discusses the altered metabolic patterns of B cells, CD4(+) T cells, and myeloid cells (which include macrophages) and their contribution to lupus, which indirectly supports the involvement of these cell types in lupus mechanisms, but it does not specifically address immune complex formation directly.
      - reference: PMID:29925508
        supports: PARTIAL
        snippet: TLR4(+)CXCR4(+) plasma cells drive nephritis development in systemic lupus erythematosus.
        explanation: This reference demonstrates the role of specific plasma cells in the development of lupus nephritis, implying their role in immune complex-related pathology, but does not detail the direct involvement of B cells or macrophages in immune complex formation.
      - reference: PMID:34402453
        supports: PARTIAL
        snippet: B-lymphocytes are crucial in the pathogenesis of systemic lupus erythematosus (SLE), including autoantibody production, antigen presentation, co-stimulation, and cytokine secretion.
        explanation: The reference highlights the crucial role of B cells in the pathogenesis of SLE through mechanisms such as autoantibody production, which is critical for immune complex formation. However, it does not explicitly discuss the role of plasma cells or macrophages in the context given.
      - reference: PMID:22999705
        supports: PARTIAL
        snippet: C1q opsonized apoptotic cells also exert an immunosuppressive effect through cytokine regulation and the stimulation of additional opsonins by macrophages.
        explanation: "This suggests that macrophages have a role in immune complex-mediated processes through cytokine regulation and opsonin stimulation, contributing to the immune system’s activity in lupus but does not detail the involvement of B cells or plasma cells in immune complex formation."
  - name: Deposition of immune complexes in tissues
    locations:
      - Kidney
      - Skeletal Joint
      - Skin
      - Heart
      - Lung
    evidence:
      - reference: PMID:16572034
        supports: PARTIAL
        snippet: Systemic lupus erythematosus is an autoimmune disease that causes inflammation in the tissues of the brain, endothelial cells, gastrointestinal/genitourinary (GI/GU), joints, kidneys, muscles, and skin. Lupus comprises a range of multisystem disorders involving the deposition of aberrant immune complexes into tissues.
        explanation: The literature confirms the deposition of immune complexes in kidneys, joints, and skin, but does not mention the heart and lung specifically in this context.
      - reference: PMID:33841392
        supports: PARTIAL
        snippet: Systemic lupus erythematosus (SLE) is a complex chronic autoimmune disease characterized by tissue damage and widespread inflammation in response to environmental challenges. Deposition of immune complexes in kidneys glomeruli are associated with lupus nephritis, determining SLE diagnosis.
        explanation: The literature supports the deposition of immune complexes in kidney glomeruli but does not cover skeletal joints, skin, heart, or lung in this context.
      - reference: PMID:30009962
        supports: SUPPORT
        snippet: LN is characterized by glomerular kidney injury, essentially due to deposition of immune complexes involving autoantibodies against cellular components and circulating proteins.
        explanation: This confirms immune complex deposition in kidneys.
      - reference: PMID:2860699
        supports: SUPPORT
        snippet: Evidence is now slowly accumulating that substantiates that immune complex deposition, complement activation and subsequent inflammatory reaction is responsible for the majority of the cardiovascular manifestations of SLE, for example, pericarditis, myocarditis, endocarditis, coronary arteritis, coronary atherosclerosis, and systemic and pulmonary vasculitis.
        explanation: This confirms immune complex deposition in the heart.
      - reference: PMID:28900675
        supports: WRONG_STATEMENT
        snippet: Recent studies demonstrated an increased incidence of osteoporosis and peripheral and vertebral fractures in patients with systemic lupus erythematosus (SLE).
        explanation: This reference does not mention the deposition of immune complexes in skeletal joints.
      - reference: PMID:158982
        supports: SUPPORT
        snippet: Abundant evidence currently exists to suggest that immune complexes play an important role in inflammatory diseases of the lung. ... systemic lupus erythematosus have been shown to be associated with the presence of immune complexes both in lung and in the serum.
        explanation: This confirms immune complex deposition in the lung.
  - name: Inflammation And Tissue Damage
    evidence:
      - reference: PMID:22192660
        supports: SUPPORT
        snippet: Systemic lupus erythematosus is a prototypic autoimmune disease characterized by autoantibody production and immune complex formation/deposition in target organs such as the kidney. Resultant local inflammation then leads to organ damage.
        explanation: The article describes inflammation and immune complex deposition as mechanisms leading to tissue damage in SLE.
      - reference: PMID:36555640
        supports: SUPPORT
        snippet: The clinical heterogeneity of the disease is accompanied by complex disturbances affecting the immune system with inflammation and tissue damage due to loss of tolerance to nuclear antigens and the deposition of immune complexes in tissues.
        explanation: The literature explains that inflammation and tissue damage are core mechanisms in the pathology of SLE due to immune system disturbances.
      - reference: PMID:28623084
        supports: SUPPORT
        snippet: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease affecting multiple organs. A complex interaction of genetics, environment, and hormones leads to immune dysregulation and breakdown of tolerance to self-antigens, resulting in autoantibody production, inflammation, and destruction of end-organs.
        explanation: This article outlines inflammation as part of the immune dysregulation in SLE, leading to tissue damage in multiple organs.
      - reference: PMID:33841392
        supports: SUPPORT
        snippet: Systemic lupus erythematosus (SLE) is a complex chronic autoimmune disease characterized by tissue damage and widespread inflammation in response to environmental challenges.
        explanation: The study identifies widespread inflammation and tissue damage as defining characteristics of SLE.
      - reference: PMID:37712757
        supports: SUPPORT
        snippet: In the current review, we focus on the commonly affected organs (skin, kidney, and nervous system) in SLE to summarize the emerging biomarkers that show promise in disease diagnosis, monitoring and treatment response assessment.
        explanation: The review supports that inflammation and tissue damage are significant mechanisms in SLE affecting organs such as the skin, kidneys, and nervous system.
  - name: Chronic Inflammation
    evidence:
      - reference: PMID:16572034
        supports: SUPPORT
        snippet: Systemic lupus erythematosus is an autoimmune disease that causes inflammation in the tissues...
        explanation: The abstract confirms that inflammation is a key aspect of systemic lupus erythematosus pathogenesis.
      - reference: PMID:26330673
        supports: SUPPORT
        snippet: Systemic lupus erythematosus, the prototype systemic autoimmune disease, is characterized by extensive self-reactivity, inflammation, and organ system damage.
        explanation: The abstract clearly mentions inflammation as a characteristic feature of SLE.
      - reference: PMID:32237942
        supports: SUPPORT
        snippet: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that is potentially life-threatening and can affect any organ.
        explanation: The literature describes SLE as a chronic autoimmune disease affecting various organs, implying sustained inflammation over time.
      - reference: PMID:24992143
        supports: SUPPORT
        snippet: Recent evidence suggests that the inflammasome machinery is dysregulated in SLE, plays an important role in promotion of organ damage, and may mediate cross-talk between environmental triggers and the development of lupus.
        explanation: The abstract discusses the role of inflammasome and inflammation in organ damage associated with SLE, supporting the chronic inflammation mechanism.
      - reference: PMID:36555640
        supports: SUPPORT
        snippet: The clinical heterogeneity of the disease is accompanied by complex disturbances affecting the immune system with inflammation and tissue damage due to loss of tolerance to nuclear antigens and the deposition of immune complexes in tissues.
        explanation: The literature describes inflammation and tissue damage due to immune complexes, which supports chronic inflammation as a mechanism of SLE.
  - name: Flare-Ups
    description: The symptoms of lupus can worsen suddenly in episodes known as flares, which can be triggered by factors like stress, sunlight, and infections.
    evidence:
      - reference: PMID:26951252
        supports: SUPPORT
        snippet: These include exposure to UV light, infections, certain hormones, and drugs which may activate the innate and adaptive immune system, resulting in inflammation, cytotoxic effects, and clinical symptoms.
        explanation: This reference mentions the potential triggers for lupus flares, which include UV light (sunlight) and infections.
      - reference: PMID:26494589
        supports: SUPPORT
        snippet: Some triggers for these exacerbations have been identified, including infections, vaccines, pregnancy, environmental factors such as weather, stress and drugs.
        explanation: This reference specifically states that stress and infections can trigger lupus flares.
      - reference: PMID:22385883
        supports: SUPPORT
        snippet: Exposure to sunlight is one of the environmental factors involved in the pathogenesis of systemic lupus erythematosus.
        explanation: This reference confirms that sunlight exposure can trigger lupus flares.
      - reference: PMID:30488801
        supports: SUPPORT
        snippet: The cutaneous manifestations that were present included malar rash 37.69%, photosensitivity 35.10%, discoid lupus 17.63%, and hair loss 39.29%.
        explanation: This reference discusses photosensitivity (sunlight) as a significant factor, aligning with the statement's mention of sunlight as a trigger.
phenotypes:
  - category: Cutaneoous
    name: Malar Rash
    frequency: FREQUENT
    diagnostic: true
    evidence:
      - reference: PMID:23846232
        supports: PARTIAL
        snippet: The most common clinical manifestations were malar rash (61.3%)...
        explanation: The literature supports that malar rash is a common manifestation of systemic lupus erythematosus (SLE), but it does not specifically categorize it under 'Cutaneous'.
      - reference: PMID:16966017
        supports: PARTIAL
        snippet: 'There are 3 forms of cutaneous lupus: chronic cutaneous (discoid) lupus, subacute cutaneous lupus, and acute cutaneous lupus.'
        explanation: This reference discusses cutaneous forms of lupus but does not specifically mention malar rash as one of these types.
      - reference: PMID:17711886
        supports: PARTIAL
        snippet: The common symptoms of SLE in children and adolescents include... rash...
        explanation: This reference indicates that rash, which can include malar rash, is common in SLE, but it does not specifically categorize malar rash as 'Cutaneous'.
  - category: Cutaneoous
    name: Photosensitivity
    frequency: FREQUENT
    evidence:
      - reference: PMID:15379880
        supports: SUPPORT
        snippet: Photosensitivity is one the most common manifestations of lupus erythematosus.
        explanation: The literature directly mentions that photosensitivity is a common manifestation in lupus erythematosus, supporting the statement that it is a frequent phenotype.
      - reference: PMID:30858846
        supports: NO_EVIDENCE
        snippet: No relevant information regarding photosensitivity in systemic lupus erythematosus was found in the provided summary.
      - reference: PMID:31909888
        supports: PARTIAL
        snippet: Fatigue, widespread pain, sleep dysfunction, and mood disorders are common symptoms in SLE.
        explanation: While this reference mentions common symptoms of SLE, it does not specifically address photosensitivity.
      - reference: PMID:30988213
        supports: PARTIAL
        snippet: The cutaneous manifestations of lupus erythematosus (LE) include LE-specific and LE-nonspecific skin lesions.
        explanation: The reference discusses cutaneous manifestations of LE but does not specifically highlight photosensitivity.
      - reference: PMID:31575058
        supports: PARTIAL
        snippet: The development of SLE is attributed to the breach of immunological tolerance and the interaction between SLE-susceptibility genes and various environmental factors.
        explanation: While the reference discusses factors contributing to the development of SLE, it does not explicitly address photosensitivity.
      - reference: PMID:23846232
        supports: PARTIAL
        snippet: The most common clinical manifestations were malar rash (61.3%), arthritis (52.3%), haematological disease (51.6%), oral ulcers (51%) and renal disease (40.6%).
        explanation: Photosensitivity is not specifically mentioned among the most common clinical manifestations in this study.
      - reference: PMID:29087262
        supports: SUPPORT
        snippet: Analysis revealed that photosensitivity, nephritis and thrombocytopenia were negatively associated with familial SLE.
        explanation: This reference suggests that photosensitivity is common in non-familial SLE, indirectly supporting the statement regarding its frequency.
      - reference: PMID:37236713
        supports: NO_EVIDENCE
        snippet: No specific mention of photosensitivity in the provided summary.
      - reference: PMID:34160552
        supports: NO_EVIDENCE
        snippet: No specific mention of photosensitivity in the provided summary.
      - reference: PMID:8398608
        supports: NO_EVIDENCE
        snippet: No specific mention of photosensitivity in the provided summary.
  - category: Musculoskeletal
    name: Arthritis
    frequency: FREQUENT
    evidence:
      - reference: PMID:19591780
        supports: SUPPORT
        snippet: Arthritis in systemic lupus erythematosus (SLE) is one of the most common disease manifestations. Nearly all joints can be affected by SLE, but hand and knee involvement are the most typical.
        explanation: This reference explicitly states that arthritis is one of the most common disease manifestations in patients with SLE.
      - reference: PMID:27742023
        supports: SUPPORT
        snippet: The precise nature of the disorder can be obscure and different disorders can present with similar symptoms, such as joint pain.
        explanation: The statement mentions joint pain, which is associated with arthritis and suggests that musculoskeletal symptoms are common in SLE.
      - reference: PMID:19013374
        supports: SUPPORT
        snippet: Systemic lupus erythematosus is an autoimmune and inflammatory disease characterized by a variety of symptoms, including arthropathy. The clinical presentation of joint involvement varies, ranging from arthralgia without erosions or deformity to an erosive arthropathy and severe functional disability.
        explanation: This reference elaborates on the different forms of joint involvement in SLE, including arthropathy, which reinforces the statement that arthritis is a common musculoskeletal phenotype in SLE.
      - reference: PMID:32956154
        supports: SUPPORT
        snippet: Polyautoimmunity was recorded in 15 patients with RA (13.8%), 43 with SLE (41%), and 2 controls (2.2%). ... In SLE, joint damage (OR, 2.282; p = 0.038) and anti-RNP antibodies (OR, 5.095; p = 0.028) were risk factors for polyautoimmunity...
        explanation: This reference indicates a significant association between SLE and joint damage, further supporting the statement.
  - category: Renal
    name: Kidney Involvement
    evidence:
      - reference: PMID:36251502
        supports: SUPPORT
        snippet: Among 365 patients with SLE, 36% had LN.
        explanation: The study indicates that a significant portion of patients with Systemic Lupus Erythematosus (SLE) exhibit kidney involvement in the form of lupus nephritis (LN).
      - reference: PMID:330103
        supports: SUPPORT
        snippet: 'The pathologic abnormalities present in patients with SLE have been classified as follows: minimal lupus nephritis, mild (focal) proliferative lupus nephritis, severe (diffuse) proliferative lupus nephritis, and membranous lupus nephritis.'
        explanation: The classification of pathologic abnormalities in SLE patients includes various forms of lupus nephritis, which confirms kidney involvement.
      - reference: PMID:30454753
        supports: SUPPORT
        snippet: Patients with early onset SLE tend to have a greater genetic component to their disease cause, more multisystemic involvement, and a more severe disease course, which includes greater risks for developing nephritis and end-stage kidney disease.
        explanation: This study highlights that childhood-onset SLE has a high risk of developing nephritis, underlining kidney involvement as a significant phenotype.
  - category: Hematologic
    name: Kidney Involvement
    evidence:
      - reference: PMID:34459313
        supports: PARTIAL
        snippet: 'Introduction: Systemic lupus erythematosus (SLE) may present with features of several systems, including hematological manifestations. Concomitant renal involvement and low C3 levels were significantly more frequent in patients with hematological involvement.'
        explanation: This study suggests that hematological involvement and kidney involvement can be concomitant in SLE patients, but they are not categorized together as a single phenotype of SLE.
      - reference: PMID:32725543
        supports: NO_EVIDENCE
        snippet: Kidney involvement occurs in over 50% of children and treatment decisions are guided by the histological classification.
        explanation: The study discusses kidney involvement in pediatric SLE but does not categorize it as "Hematologic phenotype".
      - reference: PMID:22312827
        supports: NO_EVIDENCE
        snippet: Systemic lupus erythematosus (SLE) is a chronic syndrome with unknown etiology and polymorphic clinical picture... Severe SLE involves glomerulonephritis, complications in the central nervous system, cardiac and pulmonary complications and major changes in the blood.
        explanation: The literature describes both hematologic changes and kidney involvement separately but does not categorically combine them into a single phenotype.
      - reference: PMID:14717922
        supports: NO_EVIDENCE
        snippet: The currently used classification reflects our understanding of the pathogenesis of the various forms of lupus nephritis... The diagnosis should also include entries for any concomitant vascular or tubulointerstitial lesions.
        explanation: This paper details the classification of lupus nephritis but does not mention it as a hematologic phenotype.
      - reference: PMID:36251502
        supports: NO_EVIDENCE
        snippet: 'CONCLUSION: This study aids in the recognition of the demographic, clinical, laboratory features, and the histological patterns of LN patients in Saudi Arabia, that probably has a role in the development and disease progression.'
        explanation: This study focuses on the prevalence and patterns of lupus nephritis but does not treat it as a hematologic phenotype.
biochemical:
  - name: Anti-Nuclear Antibodies (ANA)
    specificity: High
    frequency: 98%
    presence: Positive
    evidence:
      - reference: PMID:32884126
        supports: PARTIAL
        snippet: Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease characterized by antinuclear antibodies (ANAs) that form immune complexes that mediate pathogenesis by tissue deposition or cytokine induction.
        explanation: While ANAs are indeed characteristic of SLE, the specific frequency (98%) mentioned in the statement is not detailed in the provided literature.
      - reference: PMID:34996081
        supports: PARTIAL
        snippet: The 2019 classification criteria for systemic lupus erythematosus (SLE) includes an initial criterion requiring the presence of an antinuclear antibody (ANA), positive at a titer of at least 1:80 on HEp-2 cells, or equivalent.
        explanation: The criteria confirm the importance of ANA for SLE diagnosis, but do not explicitly confirm a 98% frequency rate.
      - reference: PMID:23456415
        supports: PARTIAL
        snippet: Antinuclear antibody was present in 79.6%.
        explanation: This report lists a frequency different from 98%, but supports the general relevance of ANA in SLE.
      - reference: PMID:22301032
        supports: PARTIAL
        snippet: Based on strong research evidence and consensus, the diagnosis of pSLE is unlikely if the ANA is negative, and most patients with SLE have a positive ANA at a titer >1:160.
        explanation: While the statement indicates the common presence of ANA in SLE, it does not confirm the 98% figure.
  - name: Anti-dsDNA Antibodies
    specificity: High
    presence: Positive
    evidence:
      - reference: PMID:29224677
        supports: SUPPORT
        snippet: Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease characterized by autoantibodies directed against numerous self-nuclear antigens.
        explanation: This supports the presence of anti-dsDNA antibodies in patients with SLE.
      - reference: PMID:20414746
        supports: SUPPORT
        snippet: Lupus nephritis (LN) remains the most common severe manifestation of systemic lupus erythematosus (SLE) characterized by the presence of autoantibodies (Abs) that are believed to play a central role in the pathogenesis of LN.
        explanation: This confirms the involvement of autoantibodies, including anti-dsDNA, in SLE and specifically lupus nephritis.
      - reference: PMID:35049409
        supports: SUPPORT
        snippet: Anti-double-stranded DNA (anti-dsDNA) autoantibodies are archetypal biomarkers found in systemic lupus erythematosus (SLE).
        explanation: This directly supports the presence and diagnostic role of anti-dsDNA antibodies in SLE.
      - reference: PMID:2203596
        supports: SUPPORT
        snippet: The prevalence of anti-dsDNA antibodies was strongly influenced by the selection criteria of the patient.
        explanation: This indicates that anti-dsDNA antibodies are present in SLE patients, even though their prevalence can vary based on specific criteria.
  - name: Anti-Smith Antibodies
    specificity: High
    presence: Positive
    evidence:
      - reference: PMID:29503043
        supports: SUPPORT
        snippet: One unique SLE target is the Smith antigen (Sm), a nuclear ribonucleoprotein complex. Sm response occurs in 25% of patients with SLE.
        explanation: The Smith antigen is a specific target in SLE, and the presence of anti-Smith antibodies (Sm) is marked, indicating high specificity.
      - reference: PMID:22301032
        supports: SUPPORT
        snippet: "patients with pSLE have a greater disease burden compared with adults... most patients with SLE have a positive ANA at a titer ≥1:160."
        explanation: "Although this article states that most patients with SLE have positive ANA, it indirectly supports the specific biomarkers like anti-Smith antibodies being essential in the disease’s manifestation."
  - name: Anti-Histone Antibodies
    notes: Common in drug-induced lupus.
    presence: Positive
    evidence:
      - reference: PMID:35383534
        supports: SUPPORT
        snippet: Anti-histone antibodies (AHAs) make their appearance in a number of systemic autoimmune diseases including systemic lupus erythematosus (SLE) and drug-induced lupus erythematosus (DILE).
        explanation: The literature specifically mentions the presence of anti-histone antibodies in systemic lupus erythematosus and drug-induced lupus erythematosus.
      - reference: PMID:35383534
        supports: PARTIAL
        snippet: AHAs, however, are probably less prevalent in DILE than once thought owing to a move away from older DILE drugs to modern biological agents which do not appear to elicit AHAs.
        explanation: While anti-histone antibodies are present in drug-induced lupus, their prevalence is reducing with the use of modern biological agents.
genetic:
  - name: HLA-DR2
    presence: Positive
    evidence:
      - reference: PMID:37801591
        supports: SUPPORT
        snippet: HLA-DR2 was significantly more frequently found in SLE patients than in controls (odds ratio [OR] = 2.05, 95% CI, 1.44-2.92, p < 0.001)... HLA-DR2 patients had an earlier onset of disease as well as a higher prevalence of oral ulcer, avascular necrosis of bone, and renal involvement (lupus nephritis).
        explanation: The study indicates that HLA-DR2 is associated with an increased susceptibility to SLE in the Taiwanese population.
  - name: HLA-DR3
    presence: Positive
    evidence:
      - reference: PMID:25546242
        supports: SUPPORT
        snippet: HLA-DR3 , DR9, DR15 were potent risk factors for SLE (1.88 [1.58, 2.23], P < 0.001; 1.24 [1.07, 1.45], P < 0.05; 1.25 [1.10, 1.43], P < 0.001, respectively).
        explanation: The study provides evidence that HLA-DR3 is a potent risk factor for systemic lupus erythematosus (SLE), supporting the statement.
      - reference: PMID:17910142
        supports: PARTIAL
        snippet: A positive HLA-DR3 anti-Ro/La antibody association was found in the patients with SLE (9/21, 43% vs 5/55, 9%; odds ratio (OR) = 7.5; CP = 0.01).
        explanation: The study finds a significant association between HLA-DR3 and the presence of anti-Ro/La antibodies in SLE patients, though it does not establish that HLA-DR3 alone is a genetic risk factor for SLE.
      - reference: PMID:6103441
        supports: NO_EVIDENCE
        snippet: It was also noted that the distribution of DR antigens in the hydralazine-SLE patients was significantly different from that in the group with idiopathic SLE.
        explanation: This study highlights differences in HLA-DR distribution between drug-induced SLE and idiopathic SLE, but it does not specifically address the genetic contribution of HLA-DR3 to idiopathic SLE.
  - name: PTPN22
    association: Associated
    evidence:
      - reference: PMID:31232672
        supports: SUPPORT
        snippet: We found that the PTPN22 polymorphisms rs1310182 A allele (p = 0.01, OR = 1.92 95% CI = 1.16-3.18), and rs1310182 AA genotype with (p < 0.001) and rs12760457 TT (p = 0.046) were associated with PSLE.
        explanation: The study indicates that certain polymorphisms in the PTPN22 gene are associated with pediatric systemic lupus erythematosus (PSLE), supporting the genetic association between PTPN22 and SLE.
  - name: STAT4
    association: Associated
    evidence:
      - reference: PMID:23912645
        supports: SUPPORT
        snippet: Our results showed a significant association between rs7574865 T allele (odds ratio (OR) = 1.50, 95 % CI = 1.18-1.92, P = 0.002) and susceptibility to SLE.
        explanation: The study found a significant association between the STAT4 gene (specifically rs7574865) and susceptibility to SLE.
      - reference: PMID:31082500
        supports: SUPPORT
        snippet: Analysis of existing transcriptomes and GWAS data identified eight up-regulated candidate genes with more than four relationships among the different pathways associated with SNPs to pinpoint the relevant loci linked to SLE... STAT4...
        explanation: This study identified STAT4 as one of the candidate genes associated with SLE through transcriptomic data analysis and pathway analysis of GWAS data.
      - reference: PMID:34525002
        supports: SUPPORT
        snippet: 'The main objective of this study was to evaluate an association between HLA, STAT4, IRF5, and BLK polymorphisms and the presence of JA in Brazilian individuals with SLE. METHODS: Patients were selected from a cohort of individuals with SLE followed at 2 rheumatology reference centers in Salvador, Bahia, Brazil.'
        explanation: The study aimed to evaluate the association between STAT4 polymorphisms and the presence of Jaccoud Arthropathy in individuals with SLE, implying an association between STAT4 and SLE.
  - name: IRF5
    association: Associated
    evidence:
      - reference: PMID:20962850
        supports: SUPPORT
        snippet: Our results replicate previously reported associations to alleles of interferon regulatory factor 5 (IRF5)... This study confirms the existence of multiple genetic risk factors for SLE...
        explanation: The study clearly identifies IRF5 as one of the genetic risk factors associated with SLE.
      - reference: PMID:26233721
        supports: SUPPORT
        snippet: This meta-analysis demonstrated the IRF5 rs2070197 polymorphism conferred susceptibility to SLE in all subjects... The IRF5 rs2070197 polymorphism was identified as risk factors for SLE...
        explanation: The meta-analysis confirms the association of IRF5 polymorphism with SLE in multiple populations.
      - reference: PMID:23251221
        supports: SUPPORT
        snippet: Interferon regulatory factor 5 (IRF5) is a transcription factor which... genetic variants of IRF5 have been strongly linked to SLE pathogenesis.
        explanation: The paper discusses the role of IRF5 in SLE pathogenesis and confirms its genetic association with the disease.
      - reference: PMID:20453440
        supports: SUPPORT
        snippet: Recent large-scale studies in the Caucasian populations identified many new susceptibility genes to systemic lupus erythematosus (SLE)... In IRF5, the risk haplotype in Caucasians was not present in Japanese... All of these genes were associated with SLE...
        explanation: The study confirms that IRF5 is associated with SLE in both Caucasian and Japanese populations.
      - reference: PMID:36245280
        supports: SUPPORT
        snippet: IRF5 plays a crucial role in the development of lupus... Genome-wide association studies have identified several systemic lupus erythematosus (SLE) risk single-nucleotide polymorphisms (SNPs) enriched in the IRF5 locus.
        explanation: The study identifies IRF5 as playing a key role in SLE development with confirmed risk SNPs.
environmental:
  - name: UV Exposure
    notes: Exacerbates disease activity.
    presence: Positive
    evidence:
      - reference: PMID:24763542
        supports: SUPPORT
        snippet: While it is known that UV radiation exposure may exacerbate pre-existing lupus, it remains unclear whether UV exposure is a risk factor for the development of SLE.
        explanation: The literature clearly states that UV radiation exposure may exacerbate pre-existing lupus, which supports the statement.
      - reference: PMID:22385883
        supports: SUPPORT
        snippet: Exposure to sunlight is one of the environmental factors involved in the pathogenesis of systemic lupus erythematosus.
        explanation: The study investigates the seasonal variation in lupus flares and correlates increased flares with increased temperature and sunshine, supporting the statement that UV exposure exacerbates disease activity.
  - name: Infection
    notes: Can trigger or worsen disease symptoms.
    presence: Positive
    evidence:
      - reference: PMID:36332998
        supports: SUPPORT
        snippet: This review focuses on SLE risk potentially associated with environmental factors including infections.
        explanation: The paper identifies infections as one of the environmental factors potentially associated with the risk of SLE, thereby supporting the statement that infections can trigger or worsen disease symptoms in SLE.
      - reference: PMID:25022358
        supports: SUPPORT
        snippet: New mechanisms for autoimmunity triggered by Epstein-Barr virus and human commensal microbiota have been described.
        explanation: This review mentions infections, specifically Epstein-Barr virus, as triggers for autoimmunity, which supports the notion that infections can influence SLE disease activity.
      - reference: PMID:38146370
        supports: SUPPORT
        snippet: The relationship between Systemic lupus erythematosus (SLE) and Epstein-Barr virus (EBV) infection has been suggested for decades, but the underlying mechanism of the EBV influence on SLE development remains to be elucidated.
        explanation: This study supports the connection between infections (specifically EBV) and SLE, further establishing that infections can trigger or worsen SLE symptoms.
  - name: Stress
    notes: Psychological stress can trigger flares.
    presence: Positive
    evidence:
      - reference: PMID:25216337
        supports: SUPPORT
        snippet: "It is currently believed that the onset of SLE and lupus flares are triggered by various environmental factors in genetically susceptible individuals… infections, sex hormones and certain medications and vaccines, have been implicated to induce SLE onset or flares..."
        explanation: This reference discusses various environmental factors that can trigger SLE flares, which supports the notion that stress, as an environmental factor, can do so as well.
      - reference: PMID:36537191
        supports: SUPPORT
        snippet: In a racially diverse sample of individuals with SLE, those who experienced an increase in stress had significantly worse disease activity and greater symptom burden at follow-up compared to those with stress levels that remained stable or declined.
        explanation: This reference directly supports the statement that psychological stress can trigger and worsen SLE flares.
      - reference: PMID:36535611
        supports: SUPPORT
        snippet: Systemic lupus erythematosus (SLE) is a heterogeneous, multisystem autoimmune disorder characterized by unpredictable disease flares.... suggesting that stress-related disorders alter the susceptibility to SLE.
        explanation: This reference indicates a link between stress-related disorders and the development or worsening of SLE.
animal_models:
  - species: Mouse
    genes:
      - Fas
    genotype: MRL/lpr strain
    alleles:
      - FAS lpr
    description: genetically prone to develop lupus-like symptoms and APS
    evidence:
      - reference: PMID:25183233
        supports: SUPPORT
        snippet: Mouse models of autoimmunity, such as (NZBxNZW)F1, MRL/MpJ-Fas(lpr) (MRL-lpr) and BXSB mice, spontaneously develop systemic lupus erythematosus (SLE)-like syndromes...
        explanation: This excerpt supports the statement by confirming that MRL/MpJ-Fas(lpr) (MRL-lpr) mice develop SLE-like syndromes.
      - reference: PMID:14550881
        supports: SUPPORT
        snippet: The association of HLA-DR4, -DR7, -DRw53 and -DQB1*0302 with aCL... can also be found in SLE...
        explanation: This excerpt supports the statement, indicating that there is an association between HLA alleles and SLE in MRL-lpr mice.
      - reference: PMID:38113962
        supports: SUPPORT
        snippet: Sle1 and Fas(lpr) are two lupus susceptibility loci that lead to manifestations of systemic lupus erythematosus.
        explanation: The snippet confirms that Fas(lpr) is a lupus susceptibility locus leading to SLE manifestations.
      - reference: PMID:28078597
        supports: SUPPORT
        snippet: This is characterized by the development of arthritis and immune complex glomerulonephrosis making this strain a useful model for studying systemic lupus erythematosus.
        explanation: This excerpt supports the statement by describing the MRL-lpr strain as a useful model for studying SLE, noting the development of relevant symptoms.
      - reference: PMID:18325838
        supports: PARTIAL
        snippet: breeding the ApoE(-/-) defect onto MRL/lpr mice all caused a modest increase of atherosclerosis...
        explanation: This excerpt partially supports the statement, indicating that breeding the ApoE(-/-) defect into MRL/lpr mice results in an increase in atherosclerosis (related to APS). However, it does not explicitly conclude a genetic predisposition to APS.
  - species: Mouse
    background: (NZB/BlNJ x NZW/LacJ)F1/J
    evidence:
      - reference: PMID:36211391
        supports: PARTIAL
        snippet: The (NZWxBXSB) F1 lupus-prone male mouse model of this disease is potentially useful to study mechanism and treatment modalities, but there is a lack of information about this model's characterization and disease progression.
        explanation: The reference discusses the (NZWxBXSB) F1 model rather than the (NZB/BlNJ x NZW/LacJ) F1/J model.
      - reference: PMID:33131691
        supports: SUPPORT
        snippet: The New Zealand Black (NZB) x New Zealand White (NZW) F1 (NZB/W F1) mouse represents the first spontaneous mouse model of SS. Considering that NZB/W F1 mice also develop a systemic lupus erythematosus (SLE)-like disease, this mouse model mimics the clinical presentation of polyautoimmunity seen in a sizable subset of SS patients.
        explanation: This reference supports the use of (NZB x NZW) F1 mice as a model for SLE.
      - reference: PMID:31943822
        supports: SUPPORT
        snippet: Lupus-prone (NZB x NZW)F1 mice that had been DNA-vaccinated with plasmids encoding Hsp70 and controls were monitored for lupus disease parameters including anti-double stranded DNA (anti-dsDNA) autoantibodies and cytokines using enzyme-linked immunosorbent assay, and for kidney function and pathology.
        explanation: This reference supports the use of (NZB x NZW)F1 mice as a model for SLE.
